Chetan Padmakar Darne

Person

Orange, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 11,713,316
- Issue date Aug 1, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyridopyrimidinonyl compounds useful as T cell activators
- Patent number 11,584,747
- Issue date Feb 21, 2023
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TGF beta receptor antagonists
- Patent number 10,961,239
- Issue date Mar 30, 2021
- Bristol-Myers Squibb Company
- Robert M. Borzilleri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 10,954,238
- Issue date Mar 23, 2021
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 10,669,272
- Issue date Jun 2, 2020
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TGF-β inhibitors
- Patent number 10,287,295
- Issue date May 14, 2019
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TGF-beta inhibitors
- Patent number 9,884,868
- Issue date Feb 6, 2018
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives a...
- Patent number 9,598,423
- Issue date Mar 21, 2017
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazoles as casein kinase 1 D/E inhibitors
- Patent number 9,556,179
- Issue date Jan 31, 2017
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibi...
- Patent number 9,475,817
- Issue date Oct 25, 2016
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors
- Patent number 9,273,058
- Issue date Mar 1, 2016
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonamide compounds useful as CYP17 inhibitors
- Patent number 8,916,553
- Issue date Dec 23, 2014
- Bristol-Myers Squibb Company
- Joel Francis Austin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydropyridothienopyrimidine compounds and methods of use thereof
- Patent number 8,501,755
- Issue date Aug 6, 2013
- Bayer Intellectual Property GmbH
- Chengzhi Zhang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20240400563
- Publication date Dec 5, 2024
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20230151007
- Publication date May 18, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PIPERAZINE DERIVATIVES USEFUL AS T CELL ACTIVATORS
- Publication number 20230118629
- Publication date Apr 20, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20230086933
- Publication date Mar 23, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20220324859
- Publication date Oct 13, 2022
- Bristol-Myers Squibb Company
- Upender VELAPARTHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210061802
- Publication date Mar 4, 2021
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20200109140
- Publication date Apr 9, 2020
- Bristol-Myers Squibb Company
- Upender VELAPARTHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGF-Beta Inhibitors
- Publication number 20200031832
- Publication date Jan 30, 2020
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGF BETA RECEPTOR ANTAGONISTS
- Publication number 20190337942
- Publication date Nov 7, 2019
- Bristol-Myers Squibb Company
- Robert M. Borzilleri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGF-Beta Inhibitors
- Publication number 20180127426
- Publication date May 10, 2018
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGF-Beta Inhibitors
- Publication number 20160257690
- Publication date Sep 8, 2016
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIB...
- Publication number 20160122358
- Publication date May 5, 2016
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SUBSTITUTED IMIDAZOLES AS CASEIN KINASE 1 D/E INHIBITORS
- Publication number 20150344481
- Publication date Dec 3, 2015
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIB...
- Publication number 20150133428
- Publication date May 14, 2015
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS
- Publication number 20140148453
- Publication date May 29, 2014
- Joel Francis Austin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tetrahydropyridothienopyrimidine Compounds and Methods of Use Thereof
- Publication number 20100298297
- Publication date Nov 25, 2010
- Bayer Healthcare AG
- Chengzhi Zhang
- C07 - ORGANIC CHEMISTRY

Chetan Padmakar Darne

Person

Patents Grantslast 30 patents

Substituted naphthyridinone compounds useful as T cell activators

Substituted pyridopyrimidinonyl compounds useful as T cell activators

TGF beta receptor antagonists

Substituted naphthyridinone compounds useful as T cell activators

Substituted naphthyridinone compounds useful as T cell activators

TGF-β inhibitors

TGF-beta inhibitors

Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives a...

Substituted imidazoles as casein kinase 1 D/E inhibitors

Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibi...

Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors

Sulfonamide compounds useful as CYP17 inhibitors

Tetrahydropyridothienopyrimidine compounds and methods of use thereof

Patents Applicationslast 30 patents

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED PIPERAZINE DERIVATIVES USEFUL AS T CELL ACTIVATORS

SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

TGF-Beta Inhibitors

TGF BETA RECEPTOR ANTAGONISTS

TGF-Beta Inhibitors

TGF-Beta Inhibitors

NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIB...

NOVEL SUBSTITUTED IMIDAZOLES AS CASEIN KINASE 1 D/E INHIBITORS

NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIB...

SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS

Tetrahydropyridothienopyrimidine Compounds and Methods of Use Thereof